|
|
|
Insider
Information: |
Torley Helen |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
683,004 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$31,666,361 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
683,004 |
|
|
Total
Value |
$31,666,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-28.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP, Chief Commercial ... |
2013-10-01 |
0 |
2011-08-29 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
|
2024-02-16 |
676,744 |
2014-09-16 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Quest Diagnostics Inc |
DGX |
Director |
2021-05-25 |
6,260 |
2018-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2022-02-12 |
4 |
D |
$34.20 |
$590,497 |
D/D |
(17,266) |
567,373 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2022-02-14 |
4 |
D |
$33.64 |
$508,805 |
D/D |
(15,125) |
580,977 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,729 |
596,102 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2022-02-15 |
4 |
D |
$34.43 |
$237,292 |
D/D |
(6,892) |
587,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,092 |
594,069 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-15 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-15 |
4 |
AS |
$54.11 |
$541,146 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-16 |
4 |
AS |
$53.90 |
$538,990 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-16 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-17 |
4 |
AS |
$52.15 |
$521,490 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-17 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-13 |
4 |
AS |
$58.64 |
$586,627 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-13 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-14 |
4 |
AS |
$58.30 |
$582,980 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-14 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-15 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-15 |
4 |
AS |
$57.29 |
$573,694 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-17 |
4 |
AS |
$50.40 |
$504,539 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-17 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-18 |
4 |
AS |
$51.05 |
$510,470 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-18 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-19 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-19 |
4 |
AS |
$52.41 |
$524,140 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-07 |
4 |
AS |
$51.26 |
$512,580 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-07 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
597,177 |
0 |
- |
|
169 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|